Coccidioidomycosis Study Group
Nonprofit profile at a glance
- EIN
- 332137384
- IRS 990-EZ coverage
- 2025–2025
- Forms available
- Form 990-EZ 2025
- Location
- Pittsburgh, PA, USA
- Phone
- 4123441414
- Rating
- 71
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Alliance/Advocacy Organizations
Reported finances
- Revenue
- $109,101
- Expenses
- $79,150
- Assets
- $29,951
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
14 people listed
Executive titles in this filing
- Neil Ampel (President)
- Antonino Catanzaro (Past President)
People named in this filing
- Neil Ampel (President)
- Antonino Catanzaro (Past President)
- Rafael Laniado-Laborin (Secretary)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
See Schedule O
What it reported doing in 2025
Fostering innovation and progress in the field and create a collaborative platform for academic and clinical professionals across the western hemisphere and global community to enhance public health outcomes
Operating model
- Revenue model
- Earned-program. 98% of the money available for current operations came from fees and other program revenue.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - The filed numbers largely add up. A relatively small share of available resources goes toward mission work and total assets are small relative to annual expenses; liquid coverage is unknown.
Rating breakdown
- Financial Efficiency: 57
- Transparency & Controls: 100
- Sustainability: 54
- Growth: NotEnoughData
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 50.2%; rating input score 50
- Program expense ratio: 69.1%; rating input score 69
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
Sustainability
- Operating margin: 27.5%; rating input score 79; 79th percentile among comparable filings
- Total-asset coverage ratio: 0.38; rating input score 31; 31st percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: Limited
- Asset growth: Limited
Details
- Where the money goes: 50.2% of revenue deployed · 69.1% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $55K in reported program spending
- Leadership: top reported pay $0 · 14 people listed
- Consistency: 6 of 6 current checks pass
- Schedules: 3 filed schedules
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Review — Financial Efficiency: Mission deployment rate scored 50/100.
- Moderate — Sustainability: Total-asset coverage ratio scored 31/100.